Gender effects of the COMT Val158Met genotype on verbal fluency in healthy adults

Molecular Medicine Reports

Volumn 8, Issue 3, 2013, Pages 837-844

  Soeiro De Souza, Marcio Gerhardt ^a   Bio, Danielle Soares ^a   David, Denise Petresco ^a   Missio, Giovani ^a   Lima, Bruno ^a   Fernandes, Fernando ^a   Machado Vieira, Rodrigo ^b   Moreno, Ricardo Alberto ^a  

^a Ponce School of Medicine   (Brazil)

^b Laboratory of Neuroscience (LIM 27)   (Brazil)

Author keywords

Catechol O methyltransferase; Cognition; Dopamine; Gender; Prefrontal cortex

Indexed keywords

AMINO ACID; CATECHOL METHYLTRANSFERASE; DNA; DOPAMINE; DOPAMINE RECEPTOR; METHIONINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN FUNCTION; COGNITION; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; VERBAL COMMUNICATION;

ADOLESCENT; ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; COGNITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; SEX FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 84881152852     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1564     Document Type: Article

References (71)

1. Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, et al: Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 53: 585-594, 1996.
2. Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS Jr, et al: Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex 11: 490-497, 2001.
3. De Vries GJ: Minireview: Sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology 145: 1063-1068, 2004.
4. Harrison PJ and Tunbridge EM: Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33: 3037-3045, 2008.
5. Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K and Jones PB: Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 164: 142-149, 2007.
6. O'Hara R, Miller E, Liao CP, Way N, Lin X and Hallmayer J: COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci Lett 409: 205-209, 2006.
7. Herlitz A, Nilsson LG and Bäckman L: Gender differences in episodic memory. Mem Cognit 25: 801-811, 1997.
8. van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Houx P, Knook DL and Westendorp RG: Cognitive function in the oldest old: women perform better than men. J Neurol Neurosurg Psychiatry 71: 29-32, 2001.
9. Halari R, Hines M, Kumari V, Mehrotra R, Wheeler M, Ng V and Sharma T: Sex differences and individual differences in cognitive performance and their relationship to endogenous gonadal hormones and gonadotropins. Behav Neurosci 119: 104-117, 2005.
10. van Hooren SA, Valentijn AM, Bosma H, Ponds RW, van Boxtel MP and Jolles J: Cognitive functioning in healthy older adults aged 64-81: a cohort study into the effects of age, sex, and education. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 14: 40-54, 2007.
11. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al: Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807-821, 2004.
12. Wayment HK, Schenk JO and Sorg BA: Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J Neurosci 21: 35-44, 2001.
13. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D and Karayioegou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996, 1998.
14. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ and O'Donovan MC: A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73: 152-161, 2003.
15. Tunbridge E, Burnet PW, Sodhi MS and Harrison PJ: Catechol-o- methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 51: 112-118, 2004.
16. Dempster EL, Mill J, Craig IW and Collier DA: The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med Genet 7: 10, 2006.
17. Tunbridge EM, Lane TA and Harrison PJ: Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain. Am J Med Genet B Neuropsychiatr Genet 144B: 834-839, 2007.
18. Tunbridge EM, Harrison PJ and Weinberger DR: Catechol-o- methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60: 141-151, 2006.
19. Boudíková B, Szumlanski C, Maidak B and Weinshilboum R: Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48: 381-389, 1990.
20. Fähndrich E, Coper H, Christ W, Helmchen H, Müller- Oerlinghausen B and Pietzcker A: Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr Scand 61: 427-437, 1980.
21. Floderus Y and Wetterberg L: The inheritance of human erythrocyte catechol-O-methyltransferase activity. Clin Genet 19: 392-395, 1981.
22. Philippu G, Hoo JJ, Milech U, Argarwall DP, Schrappe O and Goedde HW: Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses. Psychiatry Res 4: 139-146, 1981.
23. Fitzgerald GA, Hamilton CA, Jones DH and Reid JL: Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond) 58: 423-425, 1980.
24. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL and Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250, 1996.
25. Weinshilboum RM, Otterness DM and Szumlanski CL: Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39: 19-52, 1999.
26. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922, 2001.
27. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, et al: Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59: 662-663, 2002.
28. Bilder RM, Volavka J, Lachman HM and Grace AA: The catechol-O- methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-1961, 2004.
29. Diamond A, Briand L, Fossella J and Gehlbach L: Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 161: 125-132, 2004.
30. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, et al: Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 11: 867-877, 797, 2006.
31. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD and Robbins TW: Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: RC65, 2000.
32. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ and Williams GV: Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 174: 3-16, 2004.
33. Caldú X, Vendrell P, Bartrés-Faz D, Clemente I, Bargalló N, Jurado MA, et al: Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37: 1437-1444, 2007.
34. Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM and Gilliam TC: Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 58: 901-907, 2005.
35. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R and Nilsson LG: COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 34: 533-539, 2004.
36. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R and Nilsson LG: Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci 17: 1018-1025, 2005.
37. Barnett JH, Scoriels L and Munafò MR: Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 64: 137-144, 2008.
38. Dennis NA, Need AC, LaBar KS, Waters-Metenier S, Cirulli ET, Kragel J, et al: COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals. Cereb Cortex 20: 672-683, 2010.
39. Solís-Ortiz S, Pérez-Luque E, Morado-Crespo L and Gutiérrez-Muñoz M: Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study. Behav Brain Funct 6: 67, 2010.
40. Soeiro de Souza MG, Machado-Vieira R, Soares Bio D, Do Prado CM and Moreno RA: COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Bipolar Disord 14: 554-564, 2012.
41. Zahrt J, Taylor JR, Mathew RG and Arnsten AF: Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535, 1997.
42. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ and Robbins TW: Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215, 2000.
43. Arnsten AFT and Li BM: Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377-1384, 2005.
44. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22-33; quiz 34-57, 1998.
45. Strauss E, Sherman EMS and Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. 3rd edition, Oxford University Press, Inc., New York, NY, 2006.
46. Wechsler D: Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation: Harcourt Brace and Company, New York, NY, 1999.
47. Wechsler D: Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, San Antonio, TX, 1981.
48. Lezak MD: Neuropsychological Assessment. Oxford University Press, Inc., New York, NY, 2004.
49. Laitinen J, Samarut J and Hölttä E: A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques 17: 316, 318, 320-322, 1994.
50. Clark L, Cools R and Robbins TW: The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 55: 41-53, 2004.
51. Kimberg DY, D'Esposito M and Farah MJ: Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8: 3581-3585, 1997.
52. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan F, et al: Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191, 2003.
53. Sprague RL and Sleator EK: Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science 198: 1274-1276, 1977.
54. Cousins DA, Butts K and Young AH: The role of dopamine in bipolar disorder. Bipolar Disord 11: 787-806, 2009.
55. Jiang H, Xie T, Ramsden DB and Ho SL: Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology 45: 1011-1018, 2003.
56. Cohn CK and Axelrod J: The effect of estradiol on catechol-O- methyltransferase activity in rat liver. Life Sci I 10: 1351-1354, 1971.
57. Lindamer LA, Lohr JB, Harris MJ and Jeste DV: Gender, estrogen, and schizophrenia. Psychopharmacol Bull 33: 221-228, 1997.
58. Halbreich U: Role of estrogen in postmenopausal depression. Neurology 48 (Suppl 7): S16-S19, 1997.
59. Colzato LS, Hertsig G, van den Wildenberg WP and Hommel B: Estrogen modulates inhibitory control in healthy human females: evidence from the stop-signal paradigm. Neuroscience 167: 709-715, 2010.
60. Gasbarri A, Pompili A, d'Onofrio A, Cifariello A, Tavares MC and Tomaz C: Working memory for emotional facial expressions: role of the estrogen in young women. Psychoneuroendocrinology 33: 964-972, 2008.
61. Andrewes D: Neuropsychology. From Theory to Practice. Psychology Press, New York, NY, 2001.
62. Devinsky O and D'Esposito M: Neurology of Cognitive and Behavioral Disorders. Oxford University Press, New York, NY, 2004.
63. Darby D and Walsh KW: Walsh's Neuropsychology: A Clinical Approach. 5th edition Elsevier Churchill Livingstone, Edinburgh, 2005.
64. Ruff RM, Light RH, Parker SB and Levin HS: Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 11: 329-338, 1996.
65. Henry JD and Beatty WW: Verbal fluency deficits in multiple sclerosis. Neuropsychologia 44: 1166-1174, 2006.
66. Bolla KI, Lindgren KN, Bonaccorsy C and Bleecker ML: Predictors of verbal fluency (FAS) in the healthy elderly. J Clin Psychol 46: 623-628, 1990.
67. Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, et al: Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Percept Mot Skills 73: 539-550, 1991.
68. Libon D, David J, Glosser G, Malamut BL, Kaplan E, Goldberg E, et al: Age, executive functions, and visuospatial functioning in healthy older adults. Neuropsychology 8: 38-43, 1994.
69. Tombaugh TN, Kozak J and Rees L: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 14: 167-177, 1999.
70. Ruff RM, Allen CC, Farrow CE, Niemann H and Wylie T: Figural fluency: differential impairment in patients with left versus right frontal lobe lesions. Arch Clin Neuropsychol 9: 41-55, 1994.
71. Miller BL and Cummings JL (eds): The Human Frontal Lobes: Functions and Disorders. 2nd edition. The Guilford Press, New York, NY, 2007.